Lupin Recalls Lisinopril and Hydrochlorothiazide Tablets Due to CGMP Deviations
Lupin Pharmaceuticals is recalling specific lots of Lisinopril and Hydrochlorothiazide tablets because they were manufactured using active ingredients that failed specifications.
- Product
- LISINOPRIL AND HYDROCHLOROTHIAZIDE — LISINOPRIL AND HYDROCHLOROTHIAZIDE (LISINOPRIL AND HYDROCHLOROTHIAZIDE)
- Category
- Drug
- Distribution
- Distributed nationwide